Miriam Gonzálezhelpmiriam.com
For journalists

Press room

Verified facts, key data and a media contact. Miriam González's case, ready to be told accurately.

Key facts

Who
Miriam González, 35, software engineer and science communicator (Region of Murcia, Spain).
Diagnosis
Metastatic HR+/HER2− breast cancer with ~80% neuroendocrine differentiation (BC-NED), FGFR1 ×13 and CCND1 ×20; SSTR2+ on Ga-68 PET. Bone-only metastases.
Why it matters
Her tumor biology falls outside standard clinical guidelines. Miriam uses artificial intelligence and an international network of specialists to push for the precision oncology the protocol does not yet contemplate.
What she needs
Funding for a bone rebiopsy with an advanced molecular panel and tissue preservation for precision analyses, reviewed by an international tumor board (WIN Consortium).
Team
One patient, an international team across 3 countries, and artificial intelligence. The project sits within "Beyond the Protocol".
Languages
Available for interviews in Spanish and English.

The case in the media

Verified coverage. Links open the original outlet.

Copy-ready text

Boilerplate for press notes, newsletters or media briefs. You can quote it as-is.

Miriam González (35, Murcia, Spain) has metastatic HR+/HER2− breast cancer with ~80% neuroendocrine differentiation (BC-NED), FGFR1 ×13 amplification and SSTR2+ on Ga-68 PET. Her tumor biology falls outside standard protocols; she is funding a bone rebiopsy with an advanced molecular panel and international review (WIN Consortium). "Beyond the Protocol" project: one patient, a team across 3 countries and AI. Web: helpmiriam.com · Donate: gofund.me/3e25cae99 · Press contact: helpmiriam.com/en/contact?role=journalist

Resources

Clinical summary and molecular profileThe science page: biomarkers, targets and the rebiopsy panel.Machine-readable factsheet (llms.txt)(opens in a new tab)A structured summary of the site for AI agents.Where the money goesExpense breakdown, funding phases and donor FAQ.How to helpFive paths by profile: medicine, press, tech, patients and donation.

Press contact

For interviews, additional data, authorized photographs or the clinical summary, write to us mentioning your outlet. Miriam or someone on the team will reply.

Contact the team

Last updated: June 2026